Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Capital Pro-Egaux Inc. announces the conclusion by its wholly owned subsidiary Technique d’usinage Sinlab Inc. of two license agreements for its Technobar and guide patents

November 21, 2012

LACHENAIE, QC, Nov. 21, 2012 /CNW Telbec/ – Capital Pro-Égaux Inc. (the
“Company”) (NEX: CPE.H) is pleased to announce the signature by its
wholly owned subsidiary, Technique d’usinage Sinlab Inc. (“Sinlab”), of
two license agreement granting non-exclusive rights to certain patents
relating to its Technobar and Technoguide technologies.

Under one of the license agreements, the Company has granted to
Utah-based corporations Delcam USA, Inc. and Delcam Holdings, Inc.
(“Delcam”), non-exclusive rights to the certain patents relating to the
Technobar and Technoguide for the entire patent term in consideration
for a lump sum payment not exceeding $50,000. Delcam is authorised
under the license agreement to make, use, have made, import, export,
market, distribute, sell and offer for sale licensed products (which
include any computer system or hardware product, including but not
limited to Delcam’s, Dent CAD PRO and DentSCAN or other software and
hardware products related thereto that would infringe on a claim of a
licensed patent) within the license territory of the world.

Under another other license agreement, the Company has granted to
Tennesse-based Cagenix, Inc. (“Cagenix”), in settlement of certain
patent litigation, non-exclusive rights to certain patents relating to
the Technobar and Technoguide for the entire patent term in
consideration for certain lump sum payments over time not exceeding in
the aggregate $125,000 and certain annual royalties expected at this
time not to exceed approximately $75,000. Under the terms of the
licence agreement, Cagenix will have the right to exploit the licensed
products (which include any product, product line, service, device,
system, component, hardware, software, any combination of the
foregoing, or other offering that is designed, branded, made, used,
sold, offered for sale, leased, purchased, licensed, imported,
exported, supplied or otherwise provided by Cagenix or an affiliate
thereof that would infringe any claim of the Sinlab patents) worldwide.

Caution regarding forward-looking statements

This news release contains certain forward-looking statements regarding
the Company’s expectation of certain royalty payments to be received
under the licence agreement with Cagenix. Such expectations are based
on certain assumptions based on currently available information. If
these assumptions prove incorrect, actual results may differ materially
from those contemplated by the forward-looking statements contained in
this press release. Factors that could lead actual results to differ
include, among others, factors that may impact Cagenix’s ability to
make sales as contemplated, which include, amongst other, market
acceptance for its products, competition, market and general economic
conditions, demand fluctuations, labour relations, future funding,
unfavourable regulations, lawsuits and legal challenges and other
risks. The Company disclaims any intention or obligation to publicly
update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise, other than as required by
securities laws.

About Pro-Égaux Inc.

Pro-Égaux through its wholly owned subsidiary, Technique d’usinage
Sinlab Inc., is a company based in Lachenaie, Quebec, specializing
mainly in the conception and design of titanium products to be used in
the dental prosthesis restoration industry.

Neither NEX, the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of NEX and the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy
of this release.

SOURCE CAPITAL PRO-EGAUX INC.


Source: PR Newswire